Treatment of Pustular Discharge from Penis Without Sexual Contact History

Diagnostic Evaluation

The Centers for Disease Control and Prevention recommends a Gram stain of urethral discharge to identify polymorphonuclear leukocytes and to look for gram-negative intracellular diplococci suggesting gonorrhea in patients with pustular discharge from the penis 1, 2
The Centers for Disease Control and Prevention suggests culture or nucleic acid amplification test (NAAT) of urethral swab or first-void urine for N. gonorrhoeae and C. trachomatis in patients with pustular discharge from the penis 1, 2, 3
The Centers for Disease Control and Prevention recommends syphilis serology and HIV testing in all cases of pustular discharge from the penis 1, 2

The Centers for Disease Control and Prevention recommends empiric treatment with ceftriaxone 250 mg IM plus doxycycline 100 mg orally twice daily for 10 days for patients with pustular discharge from the penis, as sexually transmitted infections remain the most likely cause regardless of reported sexual history 1, 2
The Centers for Disease Control and Prevention recommends ceftriaxone 250 mg IM single dose plus doxycycline 100 mg orally twice daily for 10 days as the recommended regimen for urethritis in patients with pustular discharge from the penis 1, 2

The Centers for Disease Control and Prevention notes that patients often underreport or deny sexual contact, making empiric STI treatment necessary even without acknowledged exposure 4
The Centers for Disease Control and Prevention recommends instructing patients to abstain from sexual activity for 7 days after single-dose therapy or until completion of 7-day regimens and resolution of symptoms 3
The Centers for Disease Control and Prevention recommends partner notification and treatment as mandatory even if the patient denies sexual contact, as contacts within 60 days preceding symptom onset require evaluation 1, 2

The Centers for Disease Control and Prevention recommends reassessing patients within 3 days if symptoms do not improve, and considering alternative diagnoses including abscess, tumor, or resistant organisms 1, 2
The Centers for Disease Control and Prevention suggests that test of cure is not routinely recommended unless symptoms persist, but repeat testing at 3 months is advised due to high reinfection rates 3
The Centers for Disease Control and Prevention notes that persistent discharge after appropriate treatment warrants culture for resistant organisms and consideration of Mycoplasma genitalium, which responds better to azithromycin than doxycycline 3

The Centers for Disease Control and Prevention advises against delaying treatment waiting for culture results, as this increases transmission risk and potential complications 1, 2
The Centers for Disease Control and Prevention recommends not relying solely on patient-reported sexual history to exclude STIs, as denial and recall bias are common 4
The Centers for Disease Control and Prevention advises against using fluoroquinolones as first-line therapy for suspected gonorrhea due to widespread resistance 2